Phase I/II trial of BPX-601 in patients with solid tumours

Trial Profile

Phase I/II trial of BPX-601 in patients with solid tumours

Planning
Phase of Trial: Phase I/II

Latest Information Update: 13 Mar 2017

At a glance

  • Drugs BPX 601 (Primary)
  • Indications Solid tumours
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 13 Mar 2017 This trial is expected to be initiated in the second half of 2017 and report initial data in 2018, according to a Bellicum Pharmaceuticals media release.
    • 17 Mar 2015 New trial record
    • 11 Mar 2015 This trial is expected to be initiated in the second half of 2016, according to a Bellicum Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top